Your browser doesn't support javascript.
loading
Trip13 Depletion in Liver Cancer Induces a Lipogenic Response Contributing to Plin2-Dependent Mitotic Cell Death.
Rios Garcia, Marcos; Meissburger, Bettina; Chan, Jessica; de Guia, Roldan M; Mattijssen, Frits; Roessler, Stephanie; Birkenfeld, Andreas L; Raschzok, Nathanael; Riols, Fabien; Tokarz, Janina; Giroud, Maude; Gil Lozano, Manuel; Hartleben, Goetz; Nawroth, Peter; Haid, Mark; López, Miguel; Herzig, Stephan; Berriel Diaz, Mauricio.
Afiliação
  • Rios Garcia M; Institute for Diabetes and Cancer, Helmholtz Center Munich, 85764, Neuherberg, Germany.
  • Meissburger B; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, University Hospital, 69120, Heidelberg, Germany.
  • Chan J; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany.
  • de Guia RM; NeurObesity Group, Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.
  • Mattijssen F; Joint Division Molecular Metabolic Control, DKFZ-ZMBH Alliance and Network Aging Research, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Roessler S; Institute for Diabetes and Cancer, Helmholtz Center Munich, 85764, Neuherberg, Germany.
  • Birkenfeld AL; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, University Hospital, 69120, Heidelberg, Germany.
  • Raschzok N; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany.
  • Riols F; Joint Division Molecular Metabolic Control, DKFZ-ZMBH Alliance and Network Aging Research, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany.
  • Tokarz J; Institute for Diabetes and Cancer, Helmholtz Center Munich, 85764, Neuherberg, Germany.
  • Giroud M; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, University Hospital, 69120, Heidelberg, Germany.
  • Gil Lozano M; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany.
  • Hartleben G; Institute of Pathology, Liver Cancer Center Heidelberg (LCCH), University Hospital Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany.
  • Nawroth P; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany.
  • Haid M; Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich, 72076, Tübingen, Germany.
  • López M; Department of Diabetes, School of Life Course Science, King's College London, London, WC2R 2LS, UK.
  • Herzig S; Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin 2, Berlin Institute of Health (BIH), 10117, Berlin, Germany.
  • Berriel Diaz M; Metabolomics and Proteomics Core, Helmholtz Center Munich, 85764, Neuherberg, Germany.
Adv Sci (Weinh) ; 9(29): e2104291, 2022 10.
Article em En | MEDLINE | ID: mdl-36031387
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insulinas / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insulinas / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article